One such brand, Bath and Body Works, known for its body essentials and fragrances, attracted huge crowds over the weekend.

The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.

Britain's attitude towards its medicines industry has long been strangely cool. The NHS has preferred cut price generic drugs ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

The UK and the US have agreed a deal to keep tariffs on UK pharmaceutical imports into the America at zero. Under the agreement the UK will pay more for medicines through the NHS in return for a ...

Pharmaceutical exports are expected to continue on a healthy trajectory over the next few years with products worth over $250 ...

Discover why Harrow Inc. (HROW) is a strong buy in 2024—explosive growth from Vevye, rising margins, and a $175 price target.

Outliers 2025 by Outlook Business reveals how Wockhardt’s $700M push into antibiotic innovation is paying off, with Zaynich ...

Wockhardt shares were trading 18.31% higher at Rs 1459.4 per share on BSE with a market capitalisation of Rs 23,713.14 crore ...

As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, these players are sticking around to take the modality as far as it can go.